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Involvement of the Basal Cholinergic Forebrain in the
Mediation of General (Propofol) Anesthesia
Fatem-Zohra Laalou, M.D.,* Anne Pereira de Vasconcelos, Ph.D.,† Philippe Oberling, Ph.D.,‡ He´le`ne Jeltsch, Ph.D.,†
Jean-Christophe Cassel, Ph.D.,§ Laure Pain, M.D./H.D.R.
Background: Recent studies have pointed out the involve-
ment of the basal forebrain -aminobutyric acid–mediated
system in mediating the effects of general anesthesia. In this
study, the authors asked whether the basal forebrain cholin-
ergic system is also involved in mediating the effects of
general anesthetics such as propofol.
Methods: Cholinergic lesions were produced by administra-
tion of the selective immunotoxin 192 immunoglobulin G–
saporin into the lateral ventricles, the medial septum, or the
nucleus basalis magnocellularis. The anesthetic potency of
propofol was determined using an anesthetic score with a
crossover counterbalanced design. Animals were given intra-
peritoneal propofol (25 or 50 mg/kg) repeatedly every 15 min
to set up a subanesthetic (low-dose) or anesthetic (high-dose)
state. The anesthetic score was assessed for each cumulative
dose. Control of the cholinergic depletion was performed using
histochemical acetylcholinesterase staining on brain slices.
Results: A shift from a subanesthetic state to an anesthetic
state was observed mainly in the rats with the immunotoxin
injected into the lateral ventricles or the medial septum and
vertical diagonal band of Broca, compared with controls. In
those rats, the density of acetylcholinesterase reaction products
was normal in the striatum and the thalamus, but reduced in the
cortex and the hippocampus.
Conclusion: The anesthetic potency of propofol was in-
creased in all rats with hippocampal lesions, whatever the in-
jection sites, compared with controls. These results demon-
strate that a cholinergic dysfunction in the basal forebrain
potentiates the anesthetic effects of propofol.
RECENT studies have pointed out the involvement of
specific parts of the forebrain in mediating the effects of
general anesthesia1,2 and, more precisely, a septohip-
pocampal influence on the effects of general anesthesia.
The inactivation of the medial septum (MS) or the hip-
pocampus by muscimol, a -aminobutyric acid type A
receptor agonist, decreased the dose of general anes-
thetic required to induce a loss of righting reflex in rats.2
This participation of the -aminobutyric acid–mediated
(GABAergic) septohippocampal system in mediating the
effects of general anesthetics was evidenced for both vol-
atile (halothane and isoflurane) and nonvolatile (propofol
and pentobarbital) anesthetics. However, GABAergic tar-
gets represent only a subset of the cortically projecting
and other forebrain neurons, which include also a large
amount of central cholinergic neurons. To which extent
the cholinergic basal forebrain also participates in medi-
ating general anesthesia remains to be determined. This
might be of clinical relevance because one morphofunc-
tional change of the aged brain is an impairment of the
basal forebrain cholinergic pathways.3
Central cholinergic neurotransmission has been recog-
nized as playing a role in the modulation of general
anesthesia.4–9 Drugs that affect the central cholinergic
transmission have been shown to modulate the uncon-
sciousness produced by anesthetics.10–14 For example,
physostigmine, a reversible cholinesterase inhibitor that
crosses the blood–brain barrier, increased the dose of
propofol required to induce anesthesia13 and reversed
the unconsciousness induced by propofol.14 Physiologic
studies have largely evidenced the role of the basal
forebrain cholinergic system in the maintenance of con-
sciousness by modulating the shift between the desyn-
chronized and synchronized states of cortical activa-
tion.15 The anesthetic state is also characterized by a shift
in the electroencephalogram, from a desynchronized to-
ward a synchronized electrical cortical activity, with param-
eters depending on the anesthetic agent used.16,17 The
cholinergic activation of the cortex relies mainly on the
thalamocortical pathway, but also on the cortical projec-
tions from the nucleus basalis magnocellularis (NBM),
and the hippocampocortical pathways.18,19
The purpose of the current approach was to further
study the involvement of the different cholinergic fore-
brain pathways in mediating the effects of general anes-
thesia. To address this question, we performed selective
cholinergic lesions in the basal forebrain in rats and
determined the effects of incremental doses of the gen-
eral anesthetic propofol on the setting of an anesthetic
state. The cholinergic lesion in rats was performed using
192 immunoglobulin G (IgG)–saporin, a monoclonal an-
tibody against the p75NGF receptor coupled to the ri-
bosomal toxin saporin.20–25 This neurotoxin has been
largely demonstrated to be highly selective for the cho-
linergic neurons of the basal forebrain.26 First, we per-
formed global cholinergic lesions of the basal fore-
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brain using the injection of 192 IgG-saporin into the
lateral ventricles (experiment 1) as previously de-
scribed.20,22,27 When injected into the ventricles, this
immunotoxin also reaches (and damages) part of the
Purkinje cells in the cerebellum, where p75NGF re-
ceptors are found. Therefore, in two additional experi-
ments, we examined the role of different structures of
the cholinergic basal forebrain in mediating anesthesia
by intraparenchymal administration of the immuno-
toxin. To this end, injections of 192 IgG-saporin were
performed in either the NBM (experiment 2) or the
MS/vertical limb of the diagonal band of Broca (vDBB)
(experiment 3), as previously described.28–30 In that
case, the toxin does not reach the cerebellum, and Pur-
kinje cells are preserved.
Materials and Methods
This study, including care of the animals involved,
was conducted according to the official edict pre-
sented by the French Ministry of Agriculture (Paris,
France) and the recommendations of the Declaration
of Helsinki. Therefore, these experiments were con-
ducted in an authorized laboratory and under the super-
vision of an authorized researcher (J.-C.C., No. 6212,
Animal Care Committee, Strasbourg, France). All efforts
were made to minimize animal suffering and to reduce
the number of animals used.
Animals
Our subjects were 61 Long Evans male rats (Centre
d’Elevage Rongeur Janvier, Le Genest St-Isle, France)
weighing 200–220 g; they were 3 months old at the
beginning of the experiments. All rats were housed in a
colony room maintained on a 12:12 h dark–light cycle
(lights on at 7:00 AM), with food and water provided ad
libitum. The colony and testing rooms were under con-
trolled temperature (21°  2°C).
Drugs
Propofol (10 mg/ml, Diprivan; Astra-Zeneca, Paris,
France) was prepared immediately before use and injected
intraperitoneally in a volume of 2.5 ml/kg (25 mg/kg) or 5
ml/kg (50 mg/kg). The immunotoxin 192 IgG-saporin (Ad-
vanced Targeting Systems, San Diego, CA; stock solution:
2.3 g/l phosphate-buffered saline; batch No. 17-11)
was prepared immediately before use and injected in the
lateral ventricles (experiment 1), in the nucleus basalis
(experiment 2), or in the MS (experiment 3).
Surgery
During surgery, the rats were subjected to infusions of
192 IgG-saporin to induce a cholinergic lesion or vehicle
as a control. All surgical procedures20,22 were conducted
under aseptic conditions using pentobarbital anesthesia
(65 mg/kg, intraperitoneally; Sanofi, Libourne, France).
Experiment 1: Intracerebroventricular Injection.
The rats were allocated to one of the two following
groups: rats with saporin lesions (SAPO intracerebroven-
tricular; n  14) and sham-operated controls (SHAM
intracerebroventricular; n 6). After a mini craniotomy,
injections into the lateral ventricles were performed ste-
reotaxically through a 2-l Hamilton syringe at the fol-
lowing coordinates: anterior: 0.8 mm (from bregma),
lateral: 1.4 mm (from midline), ventral: 4.3 mm
(from bregma), with the incisor bar set at the level of the
interaural line.31 After the injection, the needle was left
in situ for 5 min, retracted over 2 mm, and kept there for
another delay of 4 min before complete retraction. Rats
with saporin lesions (SAPO) received an intracerebro-
ventricular injection of 2 g of 192 IgG-saporin (2 g per
rat; 1 l/lateral ventricle, concentration 1 g/l phosphate-
buffered saline). In the control group (SHAM), rats were
operated in a similar manner, except that only phosphate-
buffered saline was injected instead of 192 IgG-saporin.
Experiment 2: Nucleus Basalis Magnocellularis
Injection. The rats were allocated to one of the two
following groups: rats with saporin lesions (SAPO NBM;
n  12) and sham-operated controls (SHAM NBM; n 
10). After a mini craniotomy during anesthesia, the rats
received stereotaxically guided injections of a total of 0.4
g (in a total volume of 0.4 l) 192 IgG-saporin into the
NBM. The sham-lesioned rats received injections of
phosphate-buffered saline. The coordinates according to
the atlas of Paxinos and Watson31 were as follows: ante-
rior: 1.0 mm (from bregma), lateral: 3.0 mm (from
midline), ventral: 6.5 mm (from bregma), with the
incisor bar set at the level of the interaural line. After
each injection, the needle was left in situ for 6 min,
retracted over 1 mm, and kept there for another delay of
4 min before complete retraction to prevent leakage of
the toxin into the injection track.28
Experiment 3: Medial Septum/Vertical Diagonal
Band of Broca Injection. The rats were allocated to
one of the two following groups: rats with saporin le-
sions (SAPO MS/vDBB; n  12) and sham-operated con-
trols (SHAM MS/vDBB; n  7). After a mini craniotomy
during anesthesia, the rats received stereotaxically guided
injections of a total of 0.8 g (in a total volume of 0.8 l)
192 IgG-saporin into the MS/vDBB. The sham-lesioned rats
received injections of phosphate-buffered saline. The coor-
dinates according to the atlas of Paxinos and Watson31
were as follows: anterior:0.6 mm (from bregma), lateral:
0.2 mm (from midline), ventral: 7.2 mm for the vDBB
and ventral: 6.5 mm for the MS (from bregma), with the
incisor bar set at the level of the interaural line. After each
injection, the needle was left in situ for 6 min, retracted
over 1 mm, and kept there for another delay of 4 min
before complete retraction to prevent leakage of the toxin
into the injection track.27
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Assessment of Anesthetic Scores
Four weeks after surgery, a delay largely sufficient for
the lesions to achieve their maximal effect, the anes-
thetic potency of propofol was determined by setting up
two different states (subanesthetic and anesthetic) using
repeated injections of two different doses of propofol
(25 or 50 mg/kg; interval 15 min) according to a cross-
over counterbalanced design at a 2-week interval.
In each experiment, the effects of propofol were as-
sessed as follows: the rat was placed in a cage in which
the temperature was maintained at 28°C using an air-
heating system. Propofol was repeatedly injected every
15 min. Ten minutes after the injection, each animal was
tested for its “anesthetic score” by an experimenter who
used the scale described hereafter. The experimenter
was blind to the surgical treatment of the rat and could
not deduce it from the behavior of the animal.
0.0: Spontaneous locomotor activity during a 1-min pe-
riod of observation.
0.2: No spontaneous locomotor activity during a 1-min
period of observation.
0.4: No motor response of orientation when placed on a
grid inclined (45°) with the head down during a
30-s period of observation. When placed in such a
position, nontreated rats usually exhibit movement
to place the head up within less than a few seconds
(approximately 4–8 s).
0.6: No righting reflex when placed on the back dur-
ing a 30-s period of observation. When placed in
such a position, nontreated rats display move-
ments to leave it within a few seconds (approxi-
mately 4 – 8 s).
0.8: No paw withdrawal reflex in response to paw
clamp pressure. We assessed the reflexive with-
drawal of the leg after a pinch of 300 g; the pinch of
300 g was applied (via Electronic Von Frey Unit
EVF3; Bioseb, Vitrolles, France) to the interdigit
region of hind paw during 30 s. If no movement of
the leg was observed, the paw withdrawal reflex
was considered to be absent.
1.0: No eye-blink reflex in response to gentle applica-
tion of a cotton tip to the cornea.
Animals in each group (SAPO or SHAM) received ei-
ther propofol by steps of 25 mg/kg to set up a “subanes-
thetic state” (no loss of righting reflex, i.e., anesthetic
score 0.6) or propofol by 50 mg/kg to set up an
“anesthetic state” (at least loss of righting reflex, i.e.,
anesthetic score 0.6; cf. fig. 1) in a counterbalanced
order at an interval of 2 weeks. The comparison of the
anesthetic scores in rats with saporin lesions with those
of sham-operated controls allowed for assessment of the
effects of the cholinergic lesion on the propofol-induced
anesthesia.
Histochemistry
Finally, for each animal, the extent of the cholinergic
depletion was assessed by measuring the histochemical
activity of acetylcholinesterase in the neocortex, the
hippocampus, the thalamus, and the striatum on coronal
brain sections.
To verify the efficiency of the cholinergic lesions, each
rat was deeply anesthetized with pentobarbital (100 mg/
kg, intraperitoneally) and subjected to a transcardiac
perfusion of 50 ml saline followed by 50 ml paraformal-
dehyde (4%, 4°C) in phosphate-buffered saline. The
brain was then removed, postfixed for 4 h in the same
fixative, cryoprotected in 30% sucrose–saline (4°C) until
it sank, and frozen at70°C. Serial coronal sections (30
m thick) were cut using a cryostat microtome
(23°C) and were thaw mounted on gelatin-coated
slides. Histochemical staining of acetylcholinesterase
was used as a marker for cholinergic innervation using
acetylthiocholine iodide (4 mM) as the substrate and
ethopropazine (0.3 mM) as an inhibitor of nonspecific
cholinesterases.22
Observations of the sections stained for acetylcholines-
terase activity were completed by quantification of op-
tical density of acetylcholinesterase reactions products30
in the frontal and parietal cortices, hippocampus, thala-
mus reticular nucleus, and striatum using a computer-
assisted image analysis system (Biocom 500; Les Ulis,
France). The density was measured bilaterally for each of
these structures defined according to the rat brain atlas
of Paxinos and Watson31 in a minimum of four brain
sections. The mean optic density was considered as a
“background” and substracted from all measures before
descriptive analysis was obtained from a value taken for
each rat in the corpus callosum, where almost no ace-
tylcholinesterase-positive reaction products could be
identified.30 The experimenter performing the optic
density assessments was not aware of the rat’s surgical
treatment and rating scores.
Fig. 1. Each animal received either intraperitoneal injection of
propofol, every 15 min, by steps to set up a subanesthetic state
(no loss of righting reflex, i.e., anesthetic score <0.6) or an
anesthetic state (at least loss of righting reflex, i.e., anesthetic
score >0.6).
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Statistical Analyses
The statistical analysis was performed similarly for ex-
periments 1, 2, and 3, using the software SYSTAT version
8.0 (Systat Software Inc., San Jose, CA).
For the behavioral experiments, the anesthetic score
was considered as the dependent variable. A previous
study found that the anesthetic score easily supports
parametric analysis.32 Data were analyzed separately for
each of the two propofol regimens: step of 25 mg/kg or
step of 50 mg/kg, because there was no significant effect
of the order of passage in each experiment (all P 
0.05). Statistical analyses were performed using two-way
analysis of variance with SHAM or SAPO assignment as a
between-subjects factor and cumulative dose as a repeated-
measures factor.
For histochemical control, a multivariate analysis of
variance was performed on the acetylcholinesterase op-
tic density with SHAM or SAPO assignment or site of
injection (intracerebroventricular, NBM, or MS/vDBB)
assignment as between-subjects factors and the brain
area as a repeated-measures factor. For each site of in-
jection, one-way analyses of variance were performed on
acetylcholinesterase optic density in the different brain
structures (data from left and right hemispheres were
averaged), namely the hippocampus, the frontal and
parietal cortices, the striatum, and the thalamic reticular
nucleus. An  level of 0.05 was considered indicative of
statistical significance.
Results
Anesthetic Scores
Experiment 1: Intracerebroventricular Injection.
After the repetitive injection of 25 mg/kg (subanesthetic
state), the anesthetic score increased as the cumulative
dose of propofol was increased, with a more pro-
nounced effect in lesioned animals as compared with the
control ones (fig. 2A). At the cumulative dose of 175
mg/kg, we observed a shift from a subanesthetic state to
an anesthetic state in SAPO rats but not in SHAM rats
(anesthetic score 0.6). Analysis of variance for re-
peated measures showed a significant effect of the group
factor (F1,18  4.64, P  0.05), a significant effect of the
cumulative dose of propofol (F6,108  20.28, P  0.05),
and a significant interaction between the two factors
(F6,108  2.62, P  0.05; fig. 2A).
After the repetitive injection of 50 mg/kg (anesthetic
state), the anesthetic score increased as the cumulative
dose of propofol was increased. This effect was more
pronounced in lesioned animals as compared with the
control ones (fig. 2B). Therefore, the anesthetic potency
of propofol was significantly increased in SAPO rats as
compared with SHAM rats. Analysis of variance for re-
peated measures showed a significant effect of the group
factor (F1,18  7.79, P  0.05) and of the cumulative
dose of propofol (F4,72  69.97, P  0.05; fig. 2B).
Experiment 2: Nucleus Basalis Magnocellularis
Injection. After the repetitive injection of 25 mg/kg
(subanesthetic state), the anesthetic score increased as
the cumulative dose of propofol was increased (fig. 3A).
However, the anesthetic score did not differ in lesioned
animals as compared with the control ones (fig. 3A).
Analysis of variance for repeated measures showed no
significant effect of the group factor, (F1,20  0.09) but
there was a significant effect of the cumulative dose of
propofol (F6,120  36.07, P  0.05), with no interaction
between the two factors.
After the repetitive injection of 50 mg/kg (anesthetic
state), the anesthetic score increased as the cumulative
dose of propofol was increased. This effect was more
pronounced in lesioned animals as compared with the
control ones (fig. 3B). Therefore, the anesthetic potency
of propofol was significantly increased in SAPO rats as
Fig. 2. The effects of propofol (intraperitoneally) were deter-
mined by the anesthetic score obtained for each cumulative
dose in rats that sustained intraventricular injections (icv) of
192 immunoglobulin G–saporin (sapo; n  14) or phosphate-
buffered saline solution (sham; n  6). Results are expressed as
mean  SEM. (A) Subanesthetic state set by repeated adminis-
tration of 25 mg/kg propofol. (B) Anesthetic state set by repeated
administration of 50 mg/kg propofol. * P < 0.05 compared with
SHAM-operated animals.
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compared with SHAM rats. Analysis of variance for re-
peated measures showed an overall significant effect of
the group factor (F1,18  5.50, P  0.05) and of the
cumulative dose of propofol (F4,72  93.34 P  0.05),
but there was no significant interaction between the two
factors (F4,72  0.49). It is particularly noteworthy that
besides the overall group effect, there was no signifi-
cant interaction. In fact, post hoc analyses using t tests
with Bonferroni correction did not evidence any sig-
nificant differences between lesioned animals as com-
pared with the control ones, whatever the cumulative
dose. Two lesioned rats died unexpectedly before
being assessed.
Experiment 3: Medial Septum/Vertical Diagonal
Band of Broca Injection. After the repetitive injection
of 25 mg/kg (subanesthetic state), the anesthetic score
increased as the cumulative dose of propofol was in-
creased, with a more pronounced effect in lesioned
animals as compared with the control ones (fig. 4A). At
the cumulative dose of 175 mg/kg, we observed a shift
from a subanesthetic state to an anesthetic state (i.e., anes-
thetic score 0.6) in SAPO rats but not in SHAM rats.
Analysis of variance for repeated measures showed a sig-
nificant effect of the group factor (F1,17 18.20, P 0.05),
a significant effect of the cumulative dose of propofol
(F6,108  15.79, P  0.05), and a significant interaction
between the two factors (F6,108  3.6, P  0.05).
After the repetitive injection of 50 mg/kg (anesthetic
state), the anesthetic score increased as the cumulative
dose of propofol was increased. This effect was more
pronounced in lesioned animals as compared with the
control ones (fig. 4B). Therefore, the anesthetic potency
Fig. 3. The effects of propofol (intraperitoneally) were deter-
mined by the anesthetic score obtained for each cumulative
dose in rats that sustained injection of 192 immunoglobulin
G–saporin (sapo; n  12) or phosphate-buffered saline solution
(sham; n  10) into the nucleus basalis magnocellularis
(nbm). Results are expressed as mean  SEM. (A) Subanes-
thetic state set by repeated administration of 25 mg/kg
propofol. (B) Anesthetic state set by repeated administration
of 50 mg/kg propofol.
Fig. 4. The effects of propofol (intraperitoneally) were deter-
mined by the anesthetic score obtained for each cumulative
dose in rats that sustained injections of 192 immunoglobulin
G–saporin (sapo; n  12) or phosphate-buffered saline solution
(sham; n  7) into the medial septum and vertical diagonal
band of Broca (ms/vdbb). Results are expressed as mean SEM.
(A) Subanesthetic state set by repeated administration of 25
mg/kg propofol. (B) Anesthetic state set by repeated adminis-
tration of 50 mg/kg propofol. * P < 0.05 compared with SHAM-
operated animals.
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of propofol was significantly increased in SAPO rats as
compared with SHAM rats. Analysis of variance for re-
peated measures showed a significant effect of the group
factor (F1,17  18.20, P  0.05) and of the cumulative
dose of propofol (F4,68  1.19, P  0.05).
Histologic Analyses
The multivariate analysis of variance showed a main
significant effect of SAPO versus SHAM (F1,55  14.60,
P  104) and a significant interaction between sites of
injection (intracerebroventricular, NBM, MS/vDBB),
brain areas, and SAPO versus SHAM (F8,220  3.89, P 
104) on the acetylcholinesterase optic densities. When
compared with SHAM, intracerebroventricular lesioned
rats exhibited significant reductions of the acetylcho-
linesterase optic densities in parietal (54% on average)
and frontal (68% on average) cortices and in the hip-
pocampus (56% on average) (all P  0.05). The ace-
tylcholinesterase optic density was not significantly
modified by the 192 IgG-saporin in the striatum and the
thalamic reticular nucleus (table 1).
When the 192 IgG-saporin was injected into the NBM,
the acetylcholinesterase optic density was significantly de-
creased in the frontal cortex (43% on average) and in the
parietal cortex (50% on average) (all P  0.05). The
acetylcholinesterase optic density, however, was not sig-
nificantly modified by 192 IgG-saporin in the hippocam-
pus, the striatum, or the thalamic reticular nucleus.
Finally, when 192 IgG-saporin was injected into the
MS/vDBB, there was a significant decrease in the acetyl-
cholinesterase optic density in the hippocampus (69%
on average) and in the frontal cortex (60% on average)
(all P  0.05). In the other anatomical structures as-
sessed, we did not observe a statistically significant mod-
ification of the staining density of acetylcholinesterase.
Examples of density and distribution of acetylcholines-
terase reaction products are shown in figure 5.
Discussion
Our results show that a general basal forebrain cholin-
ergic depletion induced by intracerebroventricular injec-
Table 1. Mean Optic Density (Arbitrary Units) of Acetylcholinesterase Reaction Products in Various Brain Structures of Rats that
Sustained Injections of 192 Immunoglobulin G–Saporin or Phosphate-buffered Saline Solution
Hippocampus Frontal Cortex Parietal Cortex Thalamic Reticular Nucleus Striatum
ICV
SHAM 0.251  0.016 0.178  0.013 0.144  0.012 0.189  0.013 0.589  0.013
SAPO 0.111  0.016* 0.058  0.007* 0.066  0.007* 0.199  0.016 0.552  0.025
NBM
SHAM 0.160  0.09 0.110  0.008 0.085  0.005 0.143  0.005 0.374  0.007
SAPO 0.142  0.006 0.062  0.004* 0.042  0.003* 0.124  0.005† 0.359  0.020
MS/vDBB
SHAM 0.226  0.027 0.123  0.018 0.122  0.013 0.279  0.018 0.567  0.021
SAPO 0.070  0.010* 0.049  0.007* 0.096  0.011 0.242  0.017 0.573  0.014
Data are presented as mean  SEM in sham-operated and lesioned rats.
* P  0.0001. † P  0.05.
ICV  intracerebroventricular; MS/vDBB  medial septum and vertical diagonal band of Broca; NBM  nucleus basalis magnocellularis; SAPO  injection of
192 immunoglobulin G–saporin; SHAM  injection of phosphate-buffered saline solution.
Fig. 5. Typical examples of acetylcholinesterase staining on coronal brain sections through the striatum (A–D) and the hippocampus
(E–H) in rats subjected to sham operation (A and E), intracerebroventricular injection of 192 immunoglobulin G–saporin (B and F),
or intraparenchymal injection of 192 immunoglobulin G–saporin, either into the nucleus basalis magnocellularis (C and G) or into
the medial septum and vertical diagonal band of Broca (D and H). Note the relative preservation of acetylcholinesterase reaction
products in the striatum (A–D) and the important depletion in the hippocampus (F and H). Scale bar  530 m.
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tions of 192 IgG-saporin (experiment 1) modulates the
anesthetic effects of propofol in rats. The total cumula-
tive dose of propofol required to shift from a subanes-
thetic state to an anesthetic one was lower in the le-
sioned rats than in the control rats. Moreover, the
anesthetic potency was significantly increased in the rats
that had sustained intracerebroventricular injections of
192 IgG-saporin as compared with the controls. In a
previous study based on a comparable basal forebrain
extent of cholinergic depletion (intracerebroventricular
injection), we observed that the sedative effect of propo-
fol, as assessed by evaluation of the locomotor effects of
the drug, was alleviated in rats subjected to basal fore-
brain cholinergic depletion.20 At first glance, these re-
sults seem contradictory with the current ones. How-
ever, in the current experiment, we observed that the
anesthetic score found after the first injection of 25
mg/kg (a dose close to that used in our previous study,
namely 30 mg/kg) was lower in the lesioned animals
than in the controls (fig. 2A), even though this difference
did not reach statistical significance. The scale used in
the current study to determine the anesthetic score is a
sensitive one and is well adapted to studying the modu-
lation of anesthetic potency after pharmacologic alter-
ation of a specific neurotransmitter system.32 After com-
bining the current results on anesthetic effects with the
previous ones on locomotor impairment,20 it becomes
clear that the basal forebrain cholinergic system modu-
lates the effects of propofol. However, the interactions
seem to depend on the various effects induced by propo-
fol. A basal forebrain cholinergic depletion (intracere-
broventricular injection) alleviates the locomotor impair-
ment induced by low doses of propofol, facilitates the
shift from a subanesthetic state to an anesthetic state,
and potentiates the anesthetic state induced by propofol.
More and more, the pharmacologic mechanisms sus-
taining different effects of propofol seem to differ ac-
cording to the brain area.1,8 Recent findings in humans
evidenced that the cortex and subcortical structures
have different sensitivities to propofol.33 Our current
results combined with our previously reported ones20
are in accord with the concept that, within the brain, the
mechanisms of action of an anesthetic might differ from
one brain area to another, which could in fine have a
dose-dependent incidence on the type of behavioral ef-
fect elicited by the anesthetic.
Importantly for locomotion and movement, no notice-
able cholinergic depletion in the adjacent striatum was
observed in any experiment, an observation that is in
accord with previous reports.20,22 When 192 IgG-saporin
is injected into the ventricles, the immunotoxin reaches
other target areas than the basal forebrain, in particular
the cerebellar Purkinje cells. No disturbance of spontane-
ous behavior and locomotor activity has been observed in
rats after administration of 192 IgG-saporin into the lateral
ventricles, the NBM, and the MS/vDBB.22,27,29,30 However,
intracerebroventricular injection of 192 IgG-saporin as
well as NBM injection may result in a motor coordination
impairment.26 One could argue that our behavioral
assessment of anesthetic potency is contaminated by
such sensorimotor biases. This is not the case. We
observed the same potentiation of anesthetic potency
of propofol for intracerebroventricular and MS/vDBB
injection, whereas the injection of 192 IgG-saporin
into the MS/vDBB has no impact on motor coordina-
tion impairment.29,30
Cholinergic neurons represent a portion of the corti-
cally projecting and other basal forebrain neurons, which
include GABAergic neurons and also various monoamin-
ergic terminals or neurons.30,34 By increasing discharges
and firing in rhythmics bursts, cholinergic neurons can
thus stimulate cortical activity. Colocalized GABAergic
basal forebrain neurons oppose these actions. Previous
studies have evidenced that the local injection of a
GABAergic agonist (muscimol) in different pathways of
the basal forebrain increased the potency of both volatile
(halothane and isoflurane) and nonvolatile (propofol and
pentobarbital) anesthetics.1,2 The immunotoxin 192 IgG-
saporin is highly selective for cholinergic neurons,21–30
and cholinergic compensations are extremely weak or
inexistent.35 Some limited consequences of the immu-
notoxin on GABAergic neurons have been described
using high to very high doses of 192 IgG-saporin (above
1 g). As a compensatory mechanism to the cholinergic
lesion in the septum, both monoaminergic and sero-
toninergic sprouting have been observed, but only
several months after surgery. At the dose of 192 IgG-
saporin used in the current study and at the delay
between surgery and behavioral assessment (4
weeks), the lesions performed do not modify noncho-
linergic markers in various brain areas, including fore-
brain nuclei or targets.30
The cholinergic activation of the cortex involved in
the maintenance of consciousness relies on different
pathways, the thalamocortical pathway, namely the cor-
tical projections from the NBM and the hippocampocor-
tical connections.36 The injection of 192 IgG-saporin
into the NBM resulted in a cholinergic depletion of the
frontal and parietal cortices (approximately 40–50%)
and a depletion of the thalamic reticular nucleus (ap-
proximately 13%) that was weak but of statistical signif-
icance. Such a cholinergic depletion was associated with
a slight increase of the anesthetic potency of propofol in
rats that underwent the NBM lesion. Indeed, the differ-
ence was present from the lowest dose onward and
remained constant throughout the cumulative dose (fig.
3B). Moreover, the total cumulative dose of propofol
required to shift from a subanesthetic state to an anes-
thetic one was not modified for these animals (fig. 3A).
Based on our results, it is not possible to conclude about
the respective involvement of the direct cholinergic cor-
tical or the thalamic projections from the NBM. The
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depletion of approximately 13% in the thalamic reticular
nucleus seemed low compared with the 40–50% deple-
tion in the frontal and parietal cortices, but it might be
sufficient to modify the anesthetic potency of propofol
via the disruption of the thalamocortical pathways. Our
results evidenced some involvement of the cholinergic
projections from the NBM in mediating the anesthetic
potency of propofol, but such involvement seemed to
differ according to the extent of the cholinergic deple-
tion relying on the site of injection of the immunotoxin
(intracerebroventricular, NBM, and MS/vDBB).
Interestingly, with regard to the cholinergic local path-
ways, it must be noted that the cholinergic lesion of the
septohippocampal pathway has a more pronounced ef-
fect in the modulation of the anesthetic potency than the
lesion of the NBM. The anesthetic potency of propofol
was significantly increased in the rats that had been
subjected to NBM (experiment 2) or MS/vDBB (experi-
ment 3) lesions, but the total cumulative dose of propo-
fol required to shift from a subanesthetic state to an
anesthetic one was decreased only after MS/vDBB le-
sions. The injection of 192 IgG-saporin into the MS/vDBB
resulted in a dramatic cholinergic depletion in the hip-
pocampus (approximately 70%), but also in the frontal
cortex (approximately 60%), but there was no modifica-
tion of acetylcholinesterase optic density in the thalamic
reticular nucleus (as observed for NBM lesion). Histo-
chemical evaluation of the effects of the injections of
192 IgG-saporin into the MS/vDBB confirmed previous
observations that this injection produces a dramatic de-
pletion of acetylcholinesterase reaction products in the
hippocampus (ranging from 60% to 90% across data from
the literature).23,27 Importantly, we observed a similar
cholinergic depletion of the hippocampus after either
the intracerebroventricular or the MS/vDBB injection,
and similar effects on both anesthetic state setting and
anesthetic potency of propofol. Intracerebroventricular
and intra-MS/vDBB but not intra-NBM injection resulted
in cholinergic depletion of hippocampus in the current
study. Our results suggest that besides cholinergic corti-
cal projections from the basal forebrain, the hippocam-
pocortical pathway plays a role in mediating the anes-
thetic effects of propofol.
Recent research on the anatomical sites responsible for
general anesthesia pointed out that general anesthetics
must modify neuronal activity in more than a single brain
area simultaneously, and do so in a coordinated manner
to produce loss of consciousness and unresponsiveness.
How may the septohippocampal system participate in
general anesthesia? First, the current hippocampal lit-
erature suggests that activity of the ascending brain
stem pathways supplies the hippocampus with sen-
sory information relevant to the initiation of move-
ment. In the framework of the sensorimotor integrative
model of the hippocampus,37 the MS functions are the
node in the ascending pathways, sending both cholin-
ergic and GABAergic projections to the hippocampus,
the generation of hippocampal  band oscillation, and
synchrony being related to sensorimotor processing and
integration. Second, connection of the septohippocam-
pal pathway with the mesopontine cholinergic neurons
may help to maintain overall vigilance and influence the
sleep–wake state.38,39 The anesthetic state is associated
with a  field firing decline in the hippocampus.40
Through the above pathways, a general anesthetic might
suppress awareness and movement control. Complete
inactivation of the septohippocampal outputs, either
GABAergic ones as shown in the previous study2 or
cholinergic ones as in the current study, may facilitate
loss of consciousness and unresponsiveness and may
potentiate general anesthesia.
In summary, the injection of the 192 IgG-saporin into
the MS or in the cerebral ventricles produced a lesion
that preferentially damaged the cholinergic innervation
of the hippocampus and the frontal cortex, as previously
described. Such a cholinergic disruption was responsible
for an increased potency of propofol anesthesia in rats.
Our results suggest that the basal forebrain cholinergic
system could be a modulator (direct or indirect) for the
setting and potency of an anesthetic state. Besides cor-
tical cholinergic basal forebrain projections (as from
NBM), the septohippocampal system seemed to be in-
volved specifically in mediating general anesthesia. How-
ever, to which extent cholinergic basal forebrain path-
ways participate in the effects of other nonvolatile or
volatile anesthetics remains to be determined and is
currently under examination.
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